Development of a novel method for fabrication of solid lipid nanoparticles: Using high shear homogenization and ultrasonication

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 1, Issue 2, 2010, Pages 265-274

  Sharma, A ^a   Jindal, M ^b   Aggarwal, G ^a   Jain, S ^b  

^a Rayat Institute of Pharmacy   (India)

^b PUNJABI UNIVERSITY   (India)

Author keywords

Capsaicin; DSC; Entrapment efficiency; Solid lipid nanoparticles; Zeta potential

Indexed keywords

CAPSAICIN; SOLID LIPID NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG STABILITY; IN VITRO STUDY; LOAD CARRYING CAPACITY; NANOEMULSION; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; RELIABILITY; SCANNING ELECTRON MICROSCOPY; STORAGE TEMPERATURE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 79952586373     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fang JY, Fang CL, Liu CH, Su YH. Eur J Pharm Biopharm 2008;70: 633-40.
2. Mei Z, Chen H, Wang T, Yang Y, Yang X. Eur J Pharm Biopharm 2003;56:189-96.
3. Jenning V, Gysler A, Schäfer-Korting M, Gohla S. Eur J Pharm Biopharm 2000a;49:211-8.
4. Wissing SA, Müller RH. Eur J Pharm Biopharm 2003;56:67-72.
5. Cevc G. Adv Drug Deliv Rev 2004;56 M., Mehne:675-711.
6. Schäfer-Korting M, Korting H. Adv Drug Deliv Rev 2007;59:427-43.
7. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, Yang X. J Control Release 2006;110:296-306.
8. Maia CS, Mehnert W, Schäfer-Korting M. Int J Pharm 2000;196:165-7.
9. Maia CS, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M. J Drug Target 2001;10:489-95.
10. Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Int J Pharm 2007a;340:153-62.
11. Mei Z, Chen H, Wang T, Yang Y, Yang X. Eur J Pharm Biopharm 2003;56:189-96
12. Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M. J Control Release 2004;97:493-502.
13. Tominack RL, Spyker DA. Clin Toxicol 1987;25:591-601.
14. Hayes AG, Skingler M, Tyers MB. Neuropharmacology 1981;20:505-11.
15. Wang JP, Hsu MF, Teng CM. Thromb Res 1984;36:497-507.
16. Clozel JP, Roberts AM, Hoffman JIE, Coleridge HM, Coleridge JCG. Circ Res1985;57:450-60.
17. Fusco MM, Giacovazzo M. Drugs 1997;53:909-14.
18. Pershing LK, Reilly CA, Corlett JL, Crouch DJ. Toxicol Appl Pharmacol 2004;200:73-81.
19. Rains C, Bryson HM. Drugs Aging 1995;7:317-28.
20. Kasting GB. J Pharm Sci 2001;90:202-12.
21. Hou DZ, Xie CS, Huang KJ, Zhu CH. Biomaterials 2003;24:1781-5.
22. Sun W, Zhang N, Li A, Zou W, Xu W. Int J Pharm 2008;353:243-50.
23. Schäfer-Korting M, Mehnert W, Korting H. Adv Drug Deliv Rev 2007;59:427-43.
24. Sjostrom B, Bergenstahl B. Int J Pharm 1992;88:53-62.
25. Muller RH, Schwarz C, Mehnert W, Lucks JS. Proc Int Symp Control Rel Bioact Mater 1993;20:480-7.
26. Liedtke S, Wissing S, Muller RH, Mader K. Int J Pharm 2000;196:183-5.
27. Trotta M, Debernardi F, Caputo O. Int J Pharm 2003;257:153-60.
28. Muller RH, Jacobs C, Kayser O. Adv Drug Deliv Rev 2001;47:3-19.
29. Muller RH, Bohm BHL. In: Muller RH, Benita S, Bohm B, editors. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Stuttgart: Medpharm Scientific, 1998. p. 149-73.
30. Liversidge GC, Cundy KC. Int J Pharm 1995;127:91-7.
31. Liversidge GC. Int Symp Control Rel Bioact Mater 1996;23:74-81.
32. Levy MY, Schutze W, Fuhrer C, Benita S. J Microencapsul 1994;11:79- 92.
33. Yang SC, Zhu JB. Drug Dev Ind Pharm 2002;28:265- 74.
34. Venkateswarlu V, Manjunath K. J Control Release 2004;95:627-38.
35. Jenning V, Gysler A, Korting MS, Gohla S. Eur J Pharm Biopharm 2000;50:189-97.
36. Yuan H, Jiang SP, Du YZ, Miao J, Zhang XG, Hu FQ. Colloids Surf B Biointerfaces 2009;70:248-53.
37. Muller RH, Mader K, Gohla S. Eur J Pharm Biopharm 2000;50:161- 77.
38. Bhadra D, Bhadra S, Jain S, Jain NK. Int J Pharm 2003;257:111-24.